Target intelligence / Profile preview

Eukaryotic translation initiation factor 3 subunit M (EIF3M)

Target
EIF3M
Molecular classification
Translation initiation factor (subunit of eIF3 complex), PCI domain-containing protein, Other (since it is neither a classical receptor, enzyme, transporter, nor channel, but is a multi-subunit regulatory factor in protein synthesis)
01

Overview

Eukaryotic translation initiation factor 3 subunit M (EIF3M) is an essential component of the eIF3 multi-protein complex, which is required for initiation of protein synthesis in eukaryotic cells. EIF3M contains a PCI domain and helps define distinct subpopulations of the eIF3 complex, allowing selective binding and translation of specific mRNAs, particularly those involved in cell proliferation, apoptosis, and differentiation. It is vital for recruitment of translation initiation factors and ribosomal subunits, and its function impacts cellular protein homeostasis and quality control. Alterations or dysfunctions in EIF3M and the eIF3 complex are associated with diseases such as cancer and viral infections, making EIF3M a candidate therapeutic target, though it is not yet clinically drugged.

Other names
EIF3MeIF3mHFLB5PCID1GA17PNAS-125hFL-B5FLJ29030TANGO7Fetal lung protein B5PCI domain-containing protein 1transport and golgi organization 7 homolog (Drosophila)dendritic cell protein
02

Mechanism of action

Inhibition of protein synthesis initiation (downregulation of eIF3 function) Disruption of mRNA recruitment and ribosome assembly (theoretical/mechanistic studies)

03

Biological functions

Initiation of protein synthesismRNA recruitment and scanningRegulation of translation initiation (selection of mRNAs for translation)Cell proliferation, cycling, differentiation, and apoptosis (by controlling translation of subset of mRNAs)Disassembly/recycling of post-termination ribosomal complexesPrevention of premature ribosomal subunit joiningQuality control in protein productionProtein homeostasis and folding
04

Disease associations

Cancer (implicated in tumor progression)ApoptosisInfection (herpes simplex virus)Potential roles in neurodegenerative and other diseases via general translation control mechanismsOther: possible involvement in cystic fibrosis (via translational control of CFTR protein)
05

Safety considerations

Therapeutic targeting of EIF3M or the eIF3 complex could disrupt global protein synthesis, potentially causing cytotoxicity, impaired cell viability, and off-target effectsBroad inhibition could interfere with protein homeostasis and normal cell function
06

Interacting drugs

No directly approved drugs currently target EIF3M specifically; however, eIF3 complex and subunits have been explored as potential targets in anti-cancer strategies

2 more in the full profile.

07

Biomarkers

No widely validated biomarkers for patient selection or monitoring specifically related to EIF3MeIF3 subunit levels and mutations may be explored as future translational dysfunction markers in cancer or infection

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 3 subunit M (EIF3M).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit M (EIF3M).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call